Detalhe da pesquisa
1.
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.
Ann Oncol
; 35(4): 340-350, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159908
2.
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Ann Oncol
; 34(3): 262-274, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535565
3.
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer.
Breast Cancer Res Treat
; 182(1): 85-96, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418045
4.
Cancer gene-panel testing identifies two loss-of-function alleles in PALB2 and PTEN.
Clin Genet
; 93(6): 1250-1251, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29430632
5.
Epstein-Barr virus DNA detection by targeted sequencing in post-treatment plasma samples and prognosis of locally advanced nasopharyngeal cancer: implications for clinical research.
Ann Oncol
; 33(8): 747-749, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598800
6.
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.
Ann Oncol
; 28(8): 1923-1933, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838214
7.
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study.
Ann Oncol
; 28(9): 2213-2218, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651338
8.
The promise of immunotherapy in head and neck squamous cell carcinoma.
Ann Oncol
; 27(9): 1675-85, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380958
9.
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.
Br J Cancer
; 111(6): 1065-71, 2014 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117817
10.
The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
Ann Oncol
; 25(10): 1889-1900, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24718888
11.
The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
Ann Oncol
; 25(11): 2101-2115, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25057165
12.
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
Ann Oncol
; 25(4): 801-807, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24577117
13.
Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
Cancer Treat Rev
; 125: 102716, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492514
14.
Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Ann Oncol
; 24(8): 2124-31, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406730
15.
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Ann Oncol
; 24(4): 1011-7, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136231
16.
HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer.
Oral Dis
; 19(2): 206-11, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891969
17.
Immune checkpoint inhibitors in sarcomas: a systematic review.
Immunooncol Technol
; 20: 100407, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38192615
18.
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.
Ann Oncol
; 23(6): 1422-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22056852
19.
Radiotherapy for Hodgkin's lymphoma: too hard to die?
J BUON
; 17(1): 116-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517704
20.
The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
ESMO Open
; 6(2): 100075, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714009